TORONTO, ONTARIO--(Marketwired - Jan. 29, 2016) - The common shares of Breathtec BioMedical Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at thecse.com.
Trading Date: February 1, 2016 |
Symbol: BTH |
CUSIP: 10639L 10 1 |
ISIN: CA 10639L 10 1 3 |
Boardlot: 500 |
Business Sector: Life Sciences |
Contact Information:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com